Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine E. Calbo, Á. Díaz, E.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010 Koh Cheng Thoon, Chia Yin Chong,

Vaccines for the elderly

Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden E. Persson, S. Berg, B. Trollfors, P.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

P. Melin Clinical Microbiology and Infection

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia

Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population D. Nowakowska,

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother–infant pairs on the Thailand–Burma border

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Public health significance of invasive mosquitoes in Europe

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

Vector control: a cornerstone in the malaria elimination campaign

The role of vaccination in preventing pneumococcal disease in adults

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

CMI editorial report 2011 Clinical Microbiology and Infection

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

Can we control all-cause meningococcal disease in Europe?

Levofloxacin in the treatment of ventilator-associated pneumonia

Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study M.R. Berndsen,

Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults* P. Durando, S.N. Faust,

Metagenomics and probiotics

Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008) C. Esteva, L. Selva, M.F.

Respiratory viruses, such as 2009 H1N1 influenza virus, could trigger temporal trends in serotypes causing pneumococcal disease C. Launes, J.-J. García-García,

T.M. File Clinical Microbiology and Infection

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine

D. Schönberg-Norio, S. Sarna, M. -L. Hänninen, M. -L. Katila, S. -S

Current experience in treating invasive zygomycosis with posaconazole

Vaccines for the elderly

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine E. Calbo, Á. Díaz, E. Cañadell, J. Fábrega, S. Uriz, M. Xercavins, M.A. Morera, E. Cuchi, M. Rodríguez-Carballeira, J. Garau Clinical Microbiology and Infection Volume 12, Issue 9, Pages 867-872 (September 2006) DOI: 10.1111/j.1469-0691.2006.1502_1.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Changes in prevalence of the most common serotypes causing invasive pneumococcal disease in children aged < 5 years during 1999–2001 and 2002–2004. Clinical Microbiology and Infection 2006 12, 867-872DOI: (10.1111/j.1469-0691.2006.1502_1.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions